Rett A. On a unusual brain atrophy syndrome in hyperammonemia in childhood[J]. Wien Med Wochenschr, 1966, 116(37):723-726.
[2]
Hagberg B, Aicardi J, Dias K, et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls:Rett's syndrome:report of 35 cases[J]. Ann Neurol, 1983, 14(4):471-479.
Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2[J]. Nat Genet, 1999, 23(2):185-188.
[5]
Van Esch H, Bauters M, Ignatius J, et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males[J]. Am J Hum Genet, 2005, 77(3):442-453.
[6]
Elisa S Na, Erika D Nelson, Ege T Kavalali, et al. The impact of MeCP2 loss-or gain-of-function on synaptic plasticity[J]. Neuropsychopharmacology, 2013, 38(1):212-219.
[7]
Salomão Schwartzman J, Zatz M, dos Reis Vasquez L, et al. Rett syndrome in a boy with a 47, XXY karyotype[J]. Am J Hum Genet, 1999, 64(6):1781-1785.
[8]
Colvin L, Fyfe S, Leonard S, et al. Describing the phenotype in Rett syndrome using a population database[J]. Arch Dis Child, 2003, 88(1):38-43.
Thomas GH. High male:female ratio of germ-line mutations:an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders[J]. Am J Hum Genet. 1996, 58(6):1364-1368.
[11]
Zoghbi HY, Percy AK, Schultz RJ, et al. Patterns of X chromosome inactivation in the Rett syndrome[J]. Brain Dev, 1990, 12(1):131-135.
[12]
Amir RE, Van den Veyver IB, Schultz R, et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes[J]. Ann Neurol, 2000, 47(5):670-679.
[13]
Meins M, Lehmann J, Gerresheim F, et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome[J]. J Med Genet, 2005, 42(2):e12.
[14]
Van Esch H. MECP2 Duplication syndrome[J]. Mol Syndromol, 2012, 2(3-5):128-136.
[15]
Scott Schwoerer J, Laffin J, Haun J, et al. MECP2 duplication:possible cause of severe phenotype in females[J]. Am J Med Genet A, 2014, 164A(4):1029-1034.
[16]
Chen RZ, Akbarian S, Tudor M, et al. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice[J]. Nat Genet, 2001, 27(3):327-331.
[17]
Akbarian S. The neurobiology of Rett syndrome[J]. Neuroscientist, 2003, 9(1):57-63.
[18]
Gadalla KK, Bailey ME, Spike RC, et al. Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice[J]. Mol Ther, 2013, 21(1):18-30.
[19]
Robinson L, Guy J, McKay L, et al. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome[J]. Brain, 2012, 135(Pt 9):2699-2710.
[20]
Sztainberg Y, Chen HM, Swann JW, et al. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides[J]. Nature, 2015, 528(7580):123-126.
[21]
Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription[J]. Science, 2008, 320(5880):1224-1229.
[22]
Feldman D, Banerjee A, Sur M. Developmental dynamics of Rett syndrome[J]. Neural Plast, 2016, 2016:6154080.
[23]
Blue ME, Naidu S, Johnston MV. Development of amino acid receptors in frontal cortex from girls with Rett syndrome[J]. Ann Neurol, 1999, 45(4):541-545.
[24]
Blue ME, Naidu S, Johnston MV. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome[J]. Exp Neurol, 1999, 156(2):345-352.
[25]
Johnston MV, Ammanuel S, O'Driscoll C, et al. Twenty-four hour quantitative-EEG and in-vivo glutamate biosensor detects activity and circadian rhythm dependent biomarkers of pathogenesis in Mecp2 null mice[J]. Front Syst Neurosci, 2014, 8:118.
[26]
He LJ, Liu N, Cheng TL, et al. Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity[J]. Nat Commun, 2014, 5:5036
[27]
Bosnjak ZJ, Yan Y, Canfield S, et al. Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway[J]. Curr Drug Saf, 2012, 7(2):106-119.
[28]
Katz DM, Bird A, Coenraads M, et al. Rett Syndrome:Crossing the threshold to clinical translation[J]. Trends Neurosci, 2016, 39(2):100-113.
[29]
Durand S, Patrizi A, Quast KB, et al. NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2[J]. Neuron, 2012, 76(6):1078-1090.
[30]
Panayotis N, Pratte M, Borges-Correia A, et al. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse[J]. Neurobiol Dis, 2011, 41(2):385-397.
[31]
Abdala AP, Toward MA, Dutschmann M, et al. Deficiency of GABAergic synaptic inhibition in the Kölliker-Fuse area underlies respiratory dysrhythmia in a mouse model of Rett syndrome[J]. J Physiol, 2016, 594(1):223-237.
[32]
Zeev BB, Bebbington A, Ho G, et al. The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome[J]. Neurology, 2009, 72(14):1242-1247.
[33]
Banerjee A, Castro J, Sur M. Rett syndrome:genes, synapses, circuits, and therapeutics[J]. Front Psychiatry, 2012, 3:34.